Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

BIND Biosciences

- PMLiVE

Cancer drug spend tops $100bn in 2014

But payers are starting to bulk at increasing prices

Webinar: The patient journey: Time to look beyond the physician?

Treatment initiation is a key focus for many pharma companies as part of their strategy to increase script writing and drive greater revenues.

Research Partnership

Webcast: Biosimilars: Friend or Foe to Healthcare?

Understanding the opportunities for biosimilars and the threats to innovator biologics

Research Partnership

Anticipating the future in healthcare

New technologies will be key drivers for change

Use of biomarkers in marketing

Mark Assenti talks about utilisation of biomarkers in marketing is a trend that we have seen growing in 2014 and expect to hear even more about into 2015.

Blue Latitude Health

- PMLiVE

DNA expert: use genes to assess disease risk

Leroy Hood warns that people who opt out of genetic sequencing have their “heads in the sand”

How to confirm customer understanding in e-detailing

Done right, e-detailing takes away the guesswork in your marketing.

Anthill Agency

- PMLiVE

UK must embrace genomics or face medicines “dark age”

Life sciences minister George Freeman calls for NHS to embrace new data and technology

UK Life Sciences Strategy - one year on

NHS set to deliver ‘world-leading’ genomics centres

Genetics research plans could help create more bespoke medicines

- PMLiVE

Don’t forget email in your marketing strategy

Could it be the most underrated marketing channel in pharma?

- PMLiVE

Altering genes on demand

New award-winning research techniques could revolutionise drug discovery

- PMLiVE

Pharma lobbying in the US

Is it a matter of freedom of speech?

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links